Literature DB >> 36206034

Development of a Web-Based System to Report Medication-Related Adverse Effects: Design and Usability Study.

Renly Lim1, Christopher Thornton2, Jan Stanek3, Lisa Kalisch Ellett1, Myra Thiessen4.   

Abstract

BACKGROUND: Medicine use is the most common intervention in health care. The frequency with which medicines are used means medication-related problems are very common. One common type of medication-related problems is adverse drug events, which are unintended and harmful effects associated with use of medicines. Reporting of adverse drug events to regulatory authorities is important for evaluation of safety of medicines; however, these adverse effects are frequently unreported due to various factors, including lack of consumer-friendly reporting tools.
OBJECTIVE: The aim of this study was to develop a user-friendly digital tool for consumers to report medication-related adverse effects.
METHODS: The project consisted of 3 parts: (1) content development, including a systematic literature search; (2) iterative system development; and (3) usability testing. The project was guided by participatory design principles, which suggest involving key stakeholders throughout the design process. The first 2 versions were developed as a mobile app and were tested with end users in 2 workshops. The third version was developed as a web application and was tested with consumers who were taking regular medicines. Consumers were asked to complete a modified version of the mHealth app usability questionnaire (MAUQ), an 18-item questionnaire with each item scored using a 7-point Likert scale ranging from 0 (strongly disagree) to 7 (strongly agree). The MAUQ assessed 3 subscales including ease of use (5 items), interface and satisfaction (7 items), and usefulness (6 items). Continuous variables were reported as mean (SD) values, whereas categorical variables were presented as frequencies (percentages). Data analysis was conducted in Microsoft Excel.
RESULTS: The content for the system was based on a systematic literature search and short-listing of questions, followed by feedback from project team members and consumers. Feedback from consumers in the 2 workshops were incorporated to improve the functionality, visual design, and stability of the third (current) version. The third version of the system was tested with 26 consumers. A total of 79% (N=307/390) of all responses on the MAUQ were scored 6 or 7, indicating that users generally strongly agree with the usability of the system. When looking at the individual domains, the system had an average score of 6.3 (SD 0.9) for "ease of use," 6.3 (SD 0.8) for "interface and satisfaction," and 5.2 (SD 1.4) for "usefulness."
CONCLUSIONS: The web-based system for medicine adverse effects reporting is a user-friendly tool developed using an iterative participatory design approach. Future research includes further improving the system, particularly the usefulness of the system, as well as testing the scalability and performance of the system in practice. ©Renly Lim, Christopher Thornton, Jan Stanek, Lisa Kalisch Ellett, Myra Thiessen. Originally published in JMIR Formative Research (https://formative.jmir.org), 07.10.2022.

Entities:  

Keywords:  adverse drug event; adverse drug reaction; digital health; eHealth; mHealth; medication safety; participatory design; patient reported outcomes; telehealth

Year:  2022        PMID: 36206034      PMCID: PMC9587488          DOI: 10.2196/37605

Source DB:  PubMed          Journal:  JMIR Form Res        ISSN: 2561-326X


  24 in total

Review 1.  Effectiveness of interventions to improve adverse drug reaction reporting by healthcare professionals over the last decade: A systematic review.

Authors:  Raymond Li; Syed Tabish Razi Zaidi; Timothy Chen; Ronald Castelino
Journal:  Pharmacoepidemiol Drug Saf       Date:  2019-11-14       Impact factor: 2.890

Review 2.  The value of patient reporting to the pharmacovigilance system: a systematic review.

Authors:  Pedro Inácio; Afonso Cavaco; Marja Airaksinen
Journal:  Br J Clin Pharmacol       Date:  2016-10-12       Impact factor: 4.335

3.  Patient reporting of potential adverse drug reactions: a methodological study.

Authors:  N Jarernsiripornkul; J Krska; P A G Capps; R M E Richards; A Lee
Journal:  Br J Clin Pharmacol       Date:  2002-03       Impact factor: 4.335

4.  Development and Initial Validation of a Patient-Reported Adverse Drug Event Questionnaire.

Authors:  Sieta T de Vries; Peter G M Mol; Dick de Zeeuw; Flora M Haaijer-Ruskamp; Petra Denig
Journal:  Drug Saf       Date:  2013-09       Impact factor: 5.606

Review 5.  Under-reporting of adverse drug reactions : a systematic review.

Authors:  Lorna Hazell; Saad A W Shakir
Journal:  Drug Saf       Date:  2006       Impact factor: 5.228

6.  The mHealth App Usability Questionnaire (MAUQ): Development and Validation Study.

Authors:  Leming Zhou; Jie Bao; I Made Agus Setiawan; Andi Saptono; Bambang Parmanto
Journal:  JMIR Mhealth Uhealth       Date:  2019-04-11       Impact factor: 4.773

Review 7.  The Extent of Medication-Related Hospital Admissions in Australia: A Review from 1988 to 2021.

Authors:  Renly Lim; Lisa M Kalisch Ellett; Susan Semple; Elizabeth E Roughead
Journal:  Drug Saf       Date:  2022-01-28       Impact factor: 5.606

8.  Vertigo/dizziness as a Drugs' adverse reaction.

Authors:  Serafina Chimirri; Rossana Aiello; Carmela Mazzitello; Laura Mumoli; Caterina Palleria; Mariolina Altomonte; Rita Citraro; Giovambattista De Sarro
Journal:  J Pharmacol Pharmacother       Date:  2013-12

Review 9.  Clinical and economic burden of adverse drug reactions.

Authors:  Janet Sultana; Paola Cutroneo; Gianluca Trifirò
Journal:  J Pharmacol Pharmacother       Date:  2013-12

Review 10.  Post-marketing withdrawal of 462 medicinal products because of adverse drug reactions: a systematic review of the world literature.

Authors:  Igho J Onakpoya; Carl J Heneghan; Jeffrey K Aronson
Journal:  BMC Med       Date:  2016-02-04       Impact factor: 8.775

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.